Babu Yarlagadda S
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Babu Yarlagadda S. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BCRX | Chief Discovery Officer | Option Exercise | 50,000 | $1.42 | $71,000 | Nov 14, 2022 |
| BCRX | Chief Discovery Officer | Sale | 20,000 | $17.16 | $343,200 | Mar 7, 2022 |
| BCRX | Chief Discovery Officer | Award / Grant | 35,000 | — | — | Dec 14, 2021 |
| BCRX | Chief Discovery Officer | Option Exercise | 62,000 | $4.73 | $293,260 | Dec 7, 2021 |
| BCRX | Senior VP - Drug Discovery | Option Exercise | 50,000 | $4.15 | $207,500 | Feb 19, 2021 |
| BCRX | Senior VP - Drug Discovery | Purchase | 25,000 | $1.45 | $36,250 | Nov 18, 2019 |
| BCRX | Senior VP - Drug Discovery | Option Exercise | 19,686 | $1.20 | $23,623 | Jan 31, 2019 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 771 | $8.07 | $6,222 | Jan 1, 2019 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 15,223 | $5.18 | $78,855 | Mar 6, 2018 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 3,872 | $5.59 | $21,644 | Jan 20, 2018 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 838 | $4.91 | $4,115 | Jan 1, 2018 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 5,083 | $5.95 | $30,244 | Jan 20, 2017 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 1,639 | $6.33 | $10,375 | Jan 1, 2017 |
| BCRX | Senior VP - Drug Discovery | Sale | 30,000 | $4.06 | $121,800 | Aug 25, 2016 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 906 | $2.13 | $1,930 | Mar 1, 2016 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 4,724 | $7.55 | $35,666 | Jan 20, 2016 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 1,639 | $10.32 | $16,914 | Jan 1, 2016 |
| BCRX | Senior VP - Drug Discovery | Sale | 12,105 | $10.16 | $122,987 | Mar 19, 2015 |
| BCRX | Senior VP - Drug Discovery | Sale | 37,400 | $10.59 | $396,066 | Mar 5, 2015 |
| BCRX | Senior VP - Drug Discovery | Sale | 10,495 | $10.50 | $110,198 | Mar 4, 2015 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 1,634 | $10.20 | $16,667 | Mar 1, 2015 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 4,362 | $11.17 | $48,724 | Jan 20, 2015 |
| BCRX | Senior VP - Drug Discovery | Tax Withholding | 2,402 | $12.16 | $29,208 | Jan 1, 2015 |
| BCRX | Senior VP - Drug Discovery | Option Exercise | 23,679 | $8.83 | $209,086 | Mar 4, 2014 |
| BCRX | Senior VP - Drug Discovery | Option Exercise | 23,179 | $4.30 | $99,670 | Feb 24, 2014 |
| BCRX | Senior VP - Drug Discovery | Award / Grant | 54,000 | — | — | Jan 20, 2014 |
| BCRX | VP Drug Discovery | Tax Withholding | 2,402 | $7.60 | $18,255 | Jan 1, 2014 |
| BCRX | VP Drug Discovery | Tax Withholding | 1,903 | $1.19 | $2,265 | Mar 1, 2013 |
| BCRX | VP Drug Discovery | Award / Grant | 8,500 | — | — | Jan 1, 2013 |
| BCRX | VP Drug Discovery | Award / Grant | 21,038 | — | — | Mar 15, 2012 |
| BCRX | VP Drug Discovery | Award / Grant | 11,200 | — | — | Mar 2, 2012 |
| BCRX | VP Drug Discovery | Option Exercise | 921 | — | — | Feb 29, 2012 |
| BCRX | VP Drug Discovery | Option Exercise | 1,226 | $1.04 | $1,275 | Feb 22, 2012 |
| BCRX | VP Drug Discovery | Award / Grant | 9,000 | — | — | Mar 1, 2011 |
| BCRX | VP Drug Discovery | Tax Withholding | 6,137 | $6.46 | $39,645 | Dec 31, 2009 |
| BCRX | VP Drug Discovery | Sale | 6,400 | $10.85 | $69,440 | Oct 26, 2009 |
| BCRX | VP Drug Discovery | Sale | 200 | $10.00 | $2,000 | Oct 21, 2009 |
| BCRX | VP Drug Discovery | Sale | 3,400 | $10.00 | $34,000 | Oct 20, 2009 |
| BCRX | VP Drug Discovery | Sale | 20,000 | $9.14 | $182,800 | Sep 23, 2009 |